CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy

Biointron 2022-11-10

Authors: Anthony Cao, Jiaqing Yi, Xinyan Tang, Christopher W. Szeto, Renyi Wu, Bing Wan; Xu Fang, Shou Li, Lei Wang, Lina Wang, Jing Li, Qiuping Ye, Tom Huang, Karl Hsu, Omar Kabbarah, and Haiying Zhou

Journal: Cancer Research Communications

PubMed ID: 36970051

DOI: https://doi.org/10.1158/2767-9764.CRC-22-0266

Products & Services: Trastuzumab (anti-HER2, human IgG1), cetuximab (anti-EGFR, human IgG1), and rituximab (anti-CD20, IgG1) were acquired from Biointron

Subscribe to our Citations Database

Recommended Articles

MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma

MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IR……

Nov 25, 2025

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025